A method of using Argon gas for treating a condition associated with mu opioid receptors and/or the vesicular monoamine transporter activity in a mammal, said method comprising the steps of: a. administering a predetermined concentration of said Argon gas in order to reduce the activity of said mu receptor and of said vesicular monoamine transporter in said mammal.
